Approval · Notice of Compliance 12295 · 2011
QUEST PLUS GEL: Notice of Compliance 12295
Issued April 28, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12295
- Date
- April 28, 2011
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QUEST PLUS GEL | 02276763 | Marketed |
Medicinal ingredients
- PRAZIQUANTEL 125 MG per ML
- MOXIDECTIN 20 MG per ML